Fred Aslan
CEO of Artiva with a background spanning medicine, management consulting, venture capital, and entrepreneurship, known for leading cell-therapy efforts and prior roles at Vividion and Venrock.
Best podcasts with Fred Aslan
Ranked by the Snipd community
Feb 11, 2026 • 25min
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Fred Aslan, Artiva CEO and physician-entrepreneur with stints in VC and biotech leadership, shares his non-linear career and why curiosity guided him. He talks about CAR-T bottlenecks and how off-the-shelf NK cells could simplify and scale cell therapy. He explains why rheumatoid arthritis is the lead indication and previews registrational plans and an autoimmune basket approach.
Oct 13, 2023 • 29min
Beyond Biotech podcast 67 – natural killer cells
This week's podcast features Fred Aslan, CEO of Artiva Biotherapeutics, discussing the potential of natural killer (NK) cells in cancer treatment. They explore the challenges in developing NK cell therapy, the collaboration with AffiMed to enhance NK cell activity, upcoming milestones for the company in 2024, and the difficulties in finding participants for clinical trials in the biotech field.
